Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|June 27, 2008
Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or youngerYesim Eralp, Terry L Smith, Kadri Altundağ, et al.Cancer|October 31, 2002
Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective studyRena Vassilopoulou-Sellin, Deborah S Cohen, Gabriel N Hortobagyi, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancerLeslie K Diaz, Massimo Cristofanilli, Xiao Zhou, et al.Cancer|October 5, 2002
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemiaFrancesco Onida, Greg Ball, Hagop M Kantarjian, et al.Cancer|June 11, 2005
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimenApostolia-Maria Tsimberidou, Anas Younes, Jorge Romaguera, et al.Cannabis and Cannabinoid Research|June 18, 2021
Diacylglycerol Lipase-β Knockout Mice Display a Sex-Dependent Attenuation of Traumatic Brain Injury-Induced Mortality with No Impact on Memory or Other Functional ConsequencesLesley D O'Brien, Terry L Smith, Giulia Donvito, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancersXiaoyan Zhou, Ming Tan, Valerie Stone Hawthorne, et al.Cancer|September 24, 2004
Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatmentAna M Gonzalez-Angulo, Massimo Cristofanilli, Eric A Strom, et al.Blood|January 25, 2002
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patientsFrancesco Onida, Hagop M Kantarjian, Terry L Smith, et al.Cancer|January 28, 2004
Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinomaFrancisco J Esteva, Aysegul A Sahin, Terry L Smith, et al.Pageof 5